Fingolimod as a potent anti-Staphylococcus aureus: pH-dependent cell envelope damage and eradication of biofilms/persisters
Abstract Background The urgent need for new antibacterial drugs has driven interest in repurposing therapies to combat Gram-positive biofilms and persisters. Fingolimod, an Food and Drug Administration (FDA)-approved drug for multiple sclerosis, shows bactericidal activity, particularly against Meth...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2025-05-01
|
| Collection: | BMC Microbiology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12866-025-03973-x |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|